Iran develops domestic technology for aquaculture vaccine production
Iranian researchers develop vaccines against major bacterial diseases affecting farmed fish
Iranian researchers have developed domestic technology for producing aquaculture vaccines, an advance that could enable the country to meet demand without relying on imported products, as reported by IRNA, a TV BRICS partner.
The achievement was announced by the Tehran branch of the Academic Centre for Education, Culture and Research (ACECR), whose researchers have been working on vaccines for aquatic species for more than two decades.
Research into aquaculture vaccines began in 2005. In 2014, the team received its first production licence from Iran's Veterinary Organisation for a vaccine against streptococcosis, a bacterial disease affecting fish.
A second licence followed in 2017 for a fish vaccine against yersiniosis. Domestically developed vaccines have been used at Iranian fish farms since 2014, allowing researchers to accumulate practical experience in fish vaccination and disease prevention.
The research programme was subsequently expanded to marine fish. Since 2017, scientists have worked with cage-farming facilities in southern Iran, collecting bacterial samples and developing experimental vaccine formulations for field use.
As a result, Iranian researchers have acquired the technical expertise required to produce vaccines against streptococcosis and vibriosis in sea bass. Obtaining production approval for these vaccines is now among the research team's next objectives.
The development of domestic aquaculture vaccine technology could strengthen disease prevention in Iran's fish-farming sector while reducing dependence on imported vaccines.